Cellectar Biosciences, Inc. Resources
Patients
News & Media
Investors
Contact
Cellectar Biosciences, Inc.
Home
About
Overview
Partnerships
Management Team
Board of Directors
Platform
Overview
Posters & Publications
Product Pipeline
Overview
Iopofosine
Clinical Studies
Overview
Waldenstrom’s Macroglobulinemia Phase 2 Study
Active, not recruiting
Relapsed or Refractory Select B-Cell Malignancies Clinical Study
Active, not recruiting
Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG
Recruiting
Patients
News & Media
Investors
Contact
Press Releases
News & Media
News & Media
Press Releases
Presentations
Events
All News
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Check back soon for updates
1...
26
27
28
29
30
31
32
33
34
35